Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

PPD buys Magen BioSciences for $14.5mm in cash

Executive Summary

Concurrent with the sale of its Piedmont Research Center (provides preclinical in vivo and in vitro cancer research services) to Charles River Laboratories for $46mm, CRO Pharmaceutical Product Development (PPD) announced it acquired privately held Magen BioSciences (dermatology pharmaceuticals) for $14.5mm in cash.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition
    • Acquisition of Private Biotech
    • Intra-Biotech Deal

Related Companies